Total Payments
$3,063
2024 Payments
$607.19
Companies
36
Transactions
167
Medicare Patients
2,370
Medicare Billing
$210,229
Payment Breakdown by Category
Food & Beverage$3,063 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,063 | 167 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $602.39 | 33 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $373.60 | 18 | $0 (2024) |
| Allergan, Inc. | $243.34 | 17 | $0 (2021) |
| Merz Pharmaceuticals, LLC | $239.73 | 7 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $175.18 | 10 | $0 (2020) |
| Saol Therapeutics Inc. | $164.46 | 9 | $0 (2019) |
| Amgen Inc. | $146.13 | 8 | $0 (2019) |
| Flexion Therapeutics, Inc. | $120.51 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $71.30 | 4 | $0 (2024) |
| Medtronic, Inc. | $64.59 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $607.19 | 27 | ABBVIE INC. ($237.95) |
| 2023 | $637.16 | 32 | AbbVie Inc. ($277.94) |
| 2022 | $119.14 | 5 | ABBVIE INC. ($86.50) |
| 2021 | $19.19 | 1 | Allergan, Inc. ($19.19) |
| 2020 | $91.18 | 5 | Ipsen Biopharmaceuticals, Inc ($36.69) |
| 2019 | $648.67 | 37 | Ipsen Biopharmaceuticals, Inc ($105.54) |
| 2018 | $599.13 | 39 | Amgen Inc. ($87.48) |
| 2017 | $341.69 | 21 | MERZ NORTH AMERICA, INC. ($77.35) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 3 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Neurology | ||||||
| 04/12/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROLOGY | ||||||
| 04/05/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/15/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: non-opioid analgesic | ||||||
| 02/21/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Drug Infusion Systems | ||||||
| 02/08/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/19/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Neurology | ||||||
| 01/17/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Musculoskeletal | ||||||
| 01/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/26/2022 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Musculoskeletal | ||||||
| 09/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/30/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/23/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/11/2020 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Neurology | ||||||
| 02/27/2020 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Neurology | ||||||
| 02/18/2020 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 02/12/2020 | MERZ NORTH AMERICA, INC. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $25.03 | General |
| Category: MUSCULOSKELETAL | ||||||
| 01/16/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/17/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: ORTHOPEDICS | ||||||
| 12/12/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Neurology | ||||||
| 12/05/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $31.92 | General |
| Category: Musculoskeletal | ||||||
| 12/04/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/20/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: MUSCULOSKELETAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 727 | 1,238 | $249,028 | $66,431 |
| 2022 | 15 | 628 | 1,040 | $201,125 | $57,897 |
| 2021 | 13 | 522 | 869 | $162,185 | $46,842 |
| 2020 | 13 | 493 | 854 | $153,680 | $39,059 |
Total Patients
2,370
Total Services
4,001
Medicare Billing
$210,229
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 289 | $53,465 | $18,829 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 164 | $45,245 | $14,131 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 112 | $26,880 | $6,903 | 25.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 46 | 66 | $20,400 | $5,009 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $13,750 | $3,977 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $12,180 | $3,479 | 28.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 15 | 15 | $10,800 | $1,922 | 17.8% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 16 | 37 | $9,250 | $1,819 | 19.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 37 | $8,820 | $1,749 | 19.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 16 | 16 | $10,400 | $1,653 | 15.9% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 22 | 42 | $6,750 | $1,575 | 23.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 35 | 46 | $9,200 | $1,561 | 17.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $6,440 | $1,378 | 21.4% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 12 | 12 | $6,000 | $959.87 | 16.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 13 | 15 | $3,450 | $508.65 | 14.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,430 | $491.74 | 34.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 19 | 23 | $690.00 | $284.05 | 41.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 64 | 258 | $3,878 | $200.69 | 5.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 254 | $46,990 | $16,580 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 164 | $45,100 | $15,156 | 33.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 100 | $24,000 | $5,786 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $14,575 | $4,475 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $13,020 | $4,050 | 31.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 26 | 36 | $10,800 | $2,677 | 24.8% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2022 | 18 | 42 | $10,500 | $2,164 | 20.6% |
About Dr. Marc Strickler, M.D
Dr. Marc Strickler, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Ypsilanti, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215927397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Strickler, M.D has received a total of $3,063 in payments from pharmaceutical and medical device companies, with $607.19 received in 2024. These payments were reported across 167 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,063).
As a Medicare-enrolled provider, Strickler has provided services to 2,370 Medicare beneficiaries, totaling 4,001 services with total Medicare billing of $210,229. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Ypsilanti, MI
- Active Since 10/28/2005
- Last Updated 06/30/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1215927397
Products in Payments
- BOTOX (Biological) $565.15
- Xeomin (Biological) $317.08
- Dysport (Drug) $236.29
- DYSPORT (Drug) $142.23
- Aimovig (Biological) $131.50
- Zilretta (Drug) $120.51
- BOTOX THERAPEUTIC (Biological) $104.79
- XEOMIN (Biological) $97.83
- UBRELVY (Drug) $85.14
- QULIPTA (Drug) $75.46
- XARELTO (Drug) $71.30
- Lioresal (baclofen) (Drug) $70.64
- SYNCHROMEDII (Device) $64.59
- EUFLEXXA (Device) $57.41
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $56.93
- LYRICA (Drug) $55.64
- Lioresal Intrathecal (baclofen injection) (Drug) $55.31
- SPRIX (Drug) $48.87
- Austedo XR (Drug) $42.05
- Prialt (Drug) $41.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Ypsilanti
Dr. Jennifer Doble, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $17,442
Physical Medicine & Rehabilitation $17,442
Ari Kriswari, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,790
Physical Medicine & Rehabilitation $3,790
Dr. Jon Wardner, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,918
Physical Medicine & Rehabilitation $2,918
Ann Pattock, Pa-C, PA-C
Physical Medicine & Rehabilitation — Payments: $1,541
Physical Medicine & Rehabilitation $1,541
Dr. Stephen Bloom, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,536
Physical Medicine & Rehabilitation $1,536
Holly Pierson, Np, NP
Physical Medicine & Rehabilitation — Payments: $1,379
Physical Medicine & Rehabilitation $1,379